• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

静脉注射环孢素A期间急性肾功能损害:一种聚氧乙烯蓖麻油副作用。

Acutely impaired renal function during intravenous administration of cyclosporine A: a cremophore side-effect.

作者信息

Thiel G, Hermle M, Brunner F P

出版信息

Clin Nephrol. 1986;25 Suppl 1:S40-2.

PMID:3708935
Abstract

The parenteral application of a cyclosporine A (CyA)-containing solution in high doses, 0.7 mg/kg/min, was associated with an acute reduction in renal blood-flow and a depression in creatinine clearance to approximately one half of control values. Exactly the same effect can be produced by the intravenous administration of the vehicle, cremophore, a polyoxyethylated castor-oil derivative. Although these observations are not of great clinical importance, since the doses of CyA used in man are much lower and the drug is generally taken orally, they are of considerable importance when studying the effects of CyA under experimental conditions. For the purpose of examining the influence of CyA on renal function, cremophore-containing solutions should be avoided.

摘要

以0.7毫克/千克/分钟的高剂量肠胃外应用含环孢素A(CyA)的溶液,会导致肾血流量急性减少,肌酐清除率降低至对照值的约一半。静脉注射溶媒聚氧乙烯蓖麻油衍生物聚氧乙烯蓖麻油(cremophore)可产生完全相同的效果。尽管这些观察结果在临床上并不十分重要,因为人类使用的CyA剂量要低得多且该药物通常口服,但在研究实验条件下CyA的作用时,它们具有相当重要的意义。为了研究CyA对肾功能的影响,应避免使用含聚氧乙烯蓖麻油的溶液。

相似文献

1
Acutely impaired renal function during intravenous administration of cyclosporine A: a cremophore side-effect.静脉注射环孢素A期间急性肾功能损害:一种聚氧乙烯蓖麻油副作用。
Clin Nephrol. 1986;25 Suppl 1:S40-2.
2
Effect of cyclosporine A on ischemic renal failure in the rat.
Clin Nephrol. 1986;25 Suppl 1:S155-61.
3
Effect of cyclosporine in rats with reduced renal mass.
Clin Nephrol. 1986;25 Suppl 1:S148-54.
4
Beneficial effects of renal denervation and prazosin on GFR and renal blood flow after cyclosporine in rats.肾去神经支配和哌唑嗪对大鼠环孢素治疗后肾小球滤过率和肾血流量的有益作用。
Clin Nephrol. 1986;25 Suppl 1:S37-9.
5
Efficacy of incorporating cyclosporine into liposomes to reduce its nephrotoxicity.将环孢素包裹于脂质体中以降低其肾毒性的效果。
Can J Surg. 1988 Jan;31(1):34-6.
6
Early renal pathophysiology in an acute model of cyclosporine nephrotoxicity in rats.大鼠环孢素肾毒性急性模型中的早期肾脏病理生理学
Ren Fail. 1987;10(1):29-37. doi: 10.3109/08860228709047642.
7
NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).香豆素(CAS编号91-64-5)在F344/N大鼠和B6C3F1小鼠中的NTP毒理学和致癌性研究(灌胃研究)
Natl Toxicol Program Tech Rep Ser. 1993 Sep;422:1-340.
8
Prevention of cyclosporine (CyA) nephrotoxicity by synthetic prostaglandins.
Clin Nephrol. 1986;25 Suppl 1:S89-94.
9
Ketoconazole and cyclosporine A: combined effects on rat renal function and on serum and tissue cyclosporine A concentration.酮康唑与环孢素A:对大鼠肾功能以及血清和组织中环孢素A浓度的联合影响。
Clin Nephrol. 1986;25 Suppl 1:S137-43.
10
Acute renal failure produced by combining cyclosporine and brief renal ischemia in the Munich Wistar rat.环孢素与短暂性肾缺血联合作用诱发慕尼黑威斯塔大鼠急性肾衰竭。
Clin Nephrol. 1986;25 Suppl 1:S171-4.

引用本文的文献

1
Impact of concerning excipients on animal safety: insights for veterinary pharmacotherapy and regulatory considerations.关注赋形剂对动物安全性的影响:兽医药物治疗学的启示和监管注意事项。
Daru. 2024 Jun;32(1):289-305. doi: 10.1007/s40199-023-00486-8. Epub 2023 Oct 31.
2
Micro/nanofabricated platforms for oral drug delivery.用于口服药物递送的微纳制造平台。
J Control Release. 2015 Dec 10;219:431-444. doi: 10.1016/j.jconrel.2015.07.033. Epub 2015 Aug 2.
3
Bioequivalence and tolerability assessment of a novel intravenous ciclosporin lipid emulsion compared to branded ciclosporin in Cremophor ® EL.
新型静脉用环孢素脂质体与环孢素品牌制剂在 Cremophor EL 中的生物等效性和耐受性评估。
Clin Drug Investig. 2013 Jan;33(1):25-34. doi: 10.1007/s40261-012-0029-x.
4
Oral cyclosporine A--the current picture of its liposomal and other delivery systems.口服环孢素A——其脂质体及其他递送系统的现状
Cell Mol Biol Lett. 2009;14(1):139-52. doi: 10.2478/s11658-008-0041-6. Epub 2008 Nov 12.
5
Effects of a selective adenosine A1 receptor antagonist on the development of cyclosporin nephrotoxicity.一种选择性腺苷A1受体拮抗剂对环孢素肾毒性发展的影响。
Br J Pharmacol. 1996 Mar;117(5):879-84. doi: 10.1111/j.1476-5381.1996.tb15275.x.
6
Cyclosporin clinical pharmacokinetics.环孢素的临床药代动力学。
Clin Pharmacokinet. 1993 Jun;24(6):472-95. doi: 10.2165/00003088-199324060-00004.
7
Liposomal formulations of cyclosporin A: influence of lipid type and dose on pharmacokinetics.环孢素A脂质体制剂:脂质类型和剂量对药代动力学的影响。
Pharm Res. 1995 Aug;12(8):1189-98. doi: 10.1023/a:1016220211925.
8
Adverse reactions and interactions of cyclosporin.环孢素的不良反应及相互作用。
Med Toxicol Adverse Drug Exp. 1988 Mar-Apr;3(2):107-27. doi: 10.1007/BF03259936.
9
Significance of cyclosporin-A-associated renal surface irregularities.环孢素A相关肾表面不规则的意义。
Br J Exp Pathol. 1988 Dec;69(6):839-44.
10
Inhibition of intestinal diamine oxidase by detergents: a problem for drug formulations with water insoluble agents applied by the intravenous route?洗涤剂对肠道二胺氧化酶的抑制作用:对于通过静脉途径应用的含有水不溶性药物制剂来说是个问题吗?
Agents Actions. 1987 Apr;20(3-4):270-3. doi: 10.1007/BF02074688.